Expedition Medicines is a Biotech company based in Cambridge, MA. It has raised $50M in total funding. Latest round: Seed.
Expedition Medicines funding overview
Expedition Medicines is a Biotech company based in Cambridge, MA. Expedition Medicines has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in October 2025. The round record for Expedition Medicines runs through 2025; nothing later has been disclosed. Investors on record include Flagship Pioneering, Pfizer. 2 distinct backers are named across the disclosed rounds.
Expedition Medicines at a glance
Total raised
$50M
Latest round
Seed
Latest round date
October 2025
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
Flagship Pioneering, Pfizer
Frequently asked about Expedition Medicines funding
How much has Expedition Medicines raised?
Expedition Medicines has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Expedition Medicines?
Flagship Pioneering, Pfizer are named among the investors backing Expedition Medicines.
What was the latest Expedition Medicines funding round?
The most recent disclosed round is a Seed, announced in October 2025.
Where is Expedition Medicines based?
Expedition Medicines is based in Cambridge, MA.
What sector does Expedition Medicines operate in?
Expedition Medicines is tracked under Biotech from Cambridge, MA, with $50M in disclosed funding.
When did Expedition Medicines last raise?
The last disclosed Expedition Medicines round closed in October 2025 at Seed.
Totals shown for Expedition Medicines aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
